Morning Market Losers

Synta Pharmaceuticals

shares dipped 32.93% to $4.95 after the company reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of ganetespib in second-line non-small cell lung cancer. Infinity Pharmaceuticals

shares lost 23.41% to $20.64 on Phase 1 data. Affymax

fell 22.60% to $1.61. Affymax's PEG ratio is -0.17. National Bank of Greece SA

dropped 12.60% to $6.31. The bank's trailing-twelve-month profit margin is -98.37%